TickerFactsScreenerDevelopers

HALOZYME THERAPEUTICS, INC. (HALO) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $31.15M2018: $10.14M2019: $45.55M2020: $43.37M2021: $81.41M2022: $139.30M2023: $192.36M2024: $159.42M2025: $228.77M$228.77M
2017Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$228.77M+43.5%
2024$159.42M-17.1%
2023$192.36M+38.1%
2022$139.30M+71.1%
2021$81.41M+87.7%
2020$43.37M-4.8%
2019$45.55M+349.3%
2018$10.14M-67.5%
2017$31.15M—